Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 104701-104750 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04101630
Activity Monitoring in Pulmonary Hypertension
N/AActive, not recruiting
230 participants
Started: Oct 24, 2019 · Completed: Jan 31, 2028
1 condition1 sponsor1 location
NCT04616963
Emtricitabine/Tenofovir Alafenamide Switch Study for Transgender Individuals for HIV Pre-exposure Prophylaxis
PHASE4Active, not recruiting
64 participants
Started: Oct 24, 2019 · Completed: Jan 31, 2024
2 conditions1 sponsor1 location
NCT04165590
Plasmodium Immunotherapy for Advanced Malignant Solid Tumors
PHASE1/PHASE2Recruiting
60 participants
Started: Oct 24, 2019 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT03572465
Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis
N/ARecruiting
102 participants
Started: Oct 23, 2019 · Completed: Feb 28, 2026
2 conditions4 sponsors1 location
NCT04085510
Tomosynthesis Vs. Contrast-Enhanced Mammography in Women with Personal History of Breast Cancer in Western Pennsylvania
NAActive, not recruiting
1,647 participants
Started: Oct 23, 2019 · Completed: Jun 30, 2027
4 conditions2 sponsors3 locations
NCT04541862
Adult Intensive Care Units Database of National Taiwan University Hospital
N/ARecruiting
200,000 participants
Started: Oct 23, 2019 · Completed: Dec 31, 2043
1 condition1 sponsor1 location
NCT04006262
Pre-operative Nivolumab and Ipilimumab, Followed by Post-operative Nivolumab, for MSI/dMMR Oeso-gastric Adenocarcinoma.
PHASE2Active, not recruiting
32 participants
Started: Oct 23, 2019 · Completed: Oct 31, 2025
2 conditions2 sponsors15 locations
NCT04106518
Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver Disease
N/ARecruiting
447 participants
Started: Oct 23, 2019 · Completed: Apr 30, 2025
3 conditions1 sponsor9 locations
NCT03870919
Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients
NAActive, not recruiting
200 participants
Started: Oct 23, 2019 · Completed: Oct 23, 2027
3 conditions2 sponsors26 locations
NCT04111939
HEALing Communities Study
NAActive, not recruiting
67 participants
Started: Oct 23, 2019 · Completed: Sep 30, 2025
1 condition7 sponsors4 locations
NCT04144725
Ruling Out Coronary Artery Disease and Myocardial Injury by Biomarkers
N/ARecruiting
1,000 participants
Started: Oct 23, 2019 · Completed: Jan 31, 2030
1 condition2 sponsors1 location
NCT06919393
"Triple Negative Adult B-cell Acute Lymphoblastic Leukemia - TRINEG-ALL"
N/ARecruiting
60 participants
Started: Oct 23, 2019 · Completed: Jan 31, 2026
1 condition1 sponsor3 locations
NCT04164940
Patient Trajectories for Older Adults Admitted to Hospital for Alcohol-related Problems
N/ARecruiting
500 participants
Started: Oct 23, 2019 · Completed: Dec 31, 2030
4 conditions9 sponsors1 location
NCT04032470
Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET)
N/ARecruiting
500 participants
Started: Oct 23, 2019 · Completed: Dec 31, 2028
1 condition1 sponsor20 locations
NCT03987763
A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis
PHASE4Recruiting
45 participants
Started: Oct 22, 2019 · Completed: Jun 30, 2026
1 condition1 sponsor9 locations
NCT04115254
Stereotactic Magnetic Resonance Guided Radiation Therapy
NARecruiting
397 participants
Started: Oct 22, 2019 · Completed: Jun 30, 2028
13 conditions1 sponsor2 locations
NCT04017455
Neoadjuvant Treatment in Rectal Cancer With Radiotherapy Followed by Atezolizumab and Bevacizumab (TARZAN)
PHASE2Active, not recruiting
38 participants
Started: Oct 22, 2019 · Completed: Aug 31, 2025
1 condition2 sponsors1 location
NCT06475625
Clinical Impact of Orsiro™ Stent in Patient With Chronic Kidney Disease
PHASE4Active, not recruiting
3,113 participants
Started: Oct 22, 2019 · Completed: Jan 1, 2027
2 conditions1 sponsor1 location
NCT06550713
A Clinical Trial of TQB3455 Tablets in Patients With Hematological Malignancies
PHASE1Recruiting
100 participants
Started: Oct 22, 2019 · Completed: Dec 31, 2026
2 conditions1 sponsor7 locations
NCT04138212
Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903)
PHASE3Recruiting
456 participants
Started: Oct 22, 2019 · Completed: Dec 21, 2028
1 condition1 sponsor1 location
NCT04086368
The FDR (Femoral Derotaton) Trail.
NARecruiting
42 participants
Started: Oct 22, 2019 · Completed: Jun 15, 2031
1 condition1 sponsor1 location
NCT03984448
Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas
PHASE2/PHASE3Active, not recruiting
363 participants
Started: Oct 22, 2019 · Completed: Apr 1, 2028
8 conditions1 sponsor636 locations
NCT06136286
ORIF Distal Radius Blood Flow Restriction Therapy
NAActive, not recruiting
70 participants
Started: Oct 22, 2019 · Completed: Jan 1, 2027
1 condition1 sponsor1 location
NCT04047641
Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
PHASE1/PHASE2Recruiting
80 participants
Started: Oct 22, 2019 · Completed: Dec 31, 2025
8 conditions2 sponsors1 location
NCT04132505
Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic Cancer
PHASE1Active, not recruiting
39 participants
Started: Oct 22, 2019 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT04797403
Implementation of Multifaceted Patient-Centered Treatment Strategies for Intensive Blood Pressure Control in Minimize Cognitive Decline
NAActive, not recruiting
1,306 participants
Started: Oct 22, 2019 · Completed: Aug 31, 2026
2 conditions3 sponsors1 location
NCT04067674
Septic Shock-induced Immunosuppression
N/ARecruiting
305 participants
Started: Oct 21, 2019 · Completed: Nov 21, 2024
1 condition1 sponsor1 location
NCT02662751
Performing a Low-dose, Whole-body Angiography as the First Element of an Imaging Assessment Following Stroke / TIA
NARecruiting
260 participants
Started: Oct 21, 2019 · Completed: Jun 12, 2026
2 conditions1 sponsor2 locations
NCT03932201
Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A
N/AActive, not recruiting
371 participants
Started: Oct 21, 2019 · Completed: Mar 31, 2027
1 condition1 sponsor29 locations
NCT04074733
Diagnostic Performance of the Ultra Low-Dose (ULD) Scanner vs. Diagnostic Performance With Standard X-rays in the Emergency Department Compared With Performance of the Standard Classical-dose Scanner for Trauma of the Dorsolumbar Spine, Pelvis and Extremities
N/AActive, not recruiting
554 participants
Started: Oct 21, 2019 · Completed: Sep 12, 2025
1 condition1 sponsor4 locations
NCT04592185
The Study of the Fenestrated Anaconda Device in the Treatment of Abdominal Aortic Aneurysms
N/AActive, not recruiting
106 participants
Started: Oct 21, 2019 · Completed: Oct 31, 2025
2 conditions2 sponsors33 locations
NCT04041310
Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors
PHASE1/PHASE2Active, not recruiting
115 participants
Started: Oct 21, 2019 · Completed: Oct 30, 2026
1 condition2 sponsors46 locations
NCT04094428
Burden, Mortality and Supply Costs in Intensive Care Unit Patients
N/ARecruiting
700 participants
Started: Oct 21, 2019 · Completed: Sep 30, 2026
7 conditions1 sponsor1 location
NCT04083781
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With Inhibitors
PHASE3Active, not recruiting
134 participants
Started: Oct 21, 2019 · Completed: Feb 21, 2027
2 conditions1 sponsor86 locations
NCT04130516
Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and with Pembrolizumab
PHASE1/PHASE2Recruiting
200 participants
Started: Oct 21, 2019 · Completed: Dec 15, 2027
1 condition2 sponsors10 locations
NCT04090528
pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer
PHASE2Active, not recruiting
60 participants
Started: Oct 21, 2019 · Completed: Oct 31, 2026
3 conditions4 sponsors2 locations
NCT04416165
Comparison of FDG and FAPI in Patients With Various Types of Cancer
NARecruiting
3,000 participants
Started: Oct 20, 2019 · Completed: Dec 30, 2027
3 conditions1 sponsor1 location
NCT03936530
Infrapyloric and Greater Curvature Lymph Node Metastasis in Colon Cancer
N/AActive, not recruiting
432 participants
Started: Oct 20, 2019 · Completed: Aug 1, 2026
1 condition1 sponsor1 location
NCT04026386
A Center Based Early Intervention Program for Preschoolers with Developmental Disorders
NARecruiting
75 participants
Started: Oct 19, 2019 · Completed: Dec 30, 2034
4 conditions2 sponsors1 location
NCT03784014
Molecular Profiling of Advanced Soft-tissue Sarcomas
PHASE3Active, not recruiting
603 participants
Started: Oct 19, 2019 · Completed: Oct 31, 2025
1 condition6 sponsors19 locations
NCT03696290
Value of Inhaled Treatment With Aztreonam Lysine in Bronchiectasis
PHASE2Recruiting
77 participants
Started: Oct 19, 2019 · Completed: Sep 30, 2025
1 condition2 sponsors14 locations
NCT04094090
Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia
PHASE2Recruiting
500 participants
Started: Oct 19, 2019 · Completed: Oct 19, 2029
3 conditions1 sponsor1 location
NCT04300257
Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care
N/ARecruiting
600 participants
Started: Oct 19, 2019 · Completed: Dec 31, 2029
1 condition2 sponsors8 locations
NCT03983226
Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)
PHASE2Recruiting
167 participants
Started: Oct 18, 2019 · Completed: Dec 31, 2026
3 conditions5 sponsors5 locations
NCT04124406
Voyage: Real-World Impact of the Multi-target Stool DNA Test on CRC Screening and Mortality
N/AActive, not recruiting
150,000 participants
Started: Oct 18, 2019 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04354935
Treatment of Resistant Depression by Repetitive Transcranial Magnetic Stimulation (rTMS) Multicentric Naturalistic Study
NARecruiting
160 participants
Started: Oct 18, 2019 · Completed: Feb 28, 2026
1 condition1 sponsor2 locations
NCT03958877
A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis
PHASE3Active, not recruiting
152 participants
Started: Oct 18, 2019 · Completed: May 20, 2027
1 condition1 sponsor65 locations
NCT03913611
Shoulder Surgery Traditional vs Accelerated Rehabilitation Trial
NARecruiting
120 participants
Started: Oct 18, 2019 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location
NCT03651648
Apnea Treatment in Premature Infants Using an Automatic Vibro-tactile Stimulator Triggered by the Detection of Apnea-bradycardia.
NARecruiting
24 participants
Started: Oct 18, 2019 · Completed: Jul 2, 2024
1 condition1 sponsor1 location
NCT03908671
Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung Cancer
NARecruiting
24 participants
Started: Oct 18, 2019 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location